A-Fem Medical Announces Development Agreement.PORTLAND, Ore.--(BUSINESS WIRE)--Nov. 16, 1999-- A-Fem Medical Corporation (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :AFEM AFEM Armed Forces Expeditionary Medal AFEM Air Force Emergency Management (US Air Force) ) today announced that it has entered into a joint development agreement with the Biex Corporation of Dublin, Calif., to explore product development opportunities within complementary areas of women's healthcare. "We are excited about working with the Biex Corporation," said William H. Fleming, Vice Chairman of A-Fem Medical Corporation. "This agreement will enable both of our companies to move closer to our common commitment of improving women's health Women's Health Definition Women's health is the effect of gender on disease and health that encompasses a broad range of biological and psychosocial issues. ." Details were not disclosed. "A-Fem's three product platforms in feminine protection, point-of-care diagnostics and its proprietary vaginal fluid sample collection system offer promising opportunities in women's healthcare today and we are interested in exploring areas of mutual interest," said Dale D. Tyerman, President of Biex, Inc. Biex, Inc. is focused on developing products and services that advance women's healthcare and reduce the need for costly medical resources. Biex has developed a unique, proprietary, patented system to help identify risk in pregnant women for developing spontaneous preterm labor Preterm labor Labor before the thirty-seventh week of pregnancy. Mentioned in: Incompetent Cervix -- the salivary sal·i·var·y adj. 1. Of, relating to, or producing saliva. 2. Of or relating to a salivary gland. salivary pertaining to the saliva. estriol estriol /es·tri·ol/ (es´tre-ol) a relatively weak human estrogen (q.v.), being a metabolic product of estradiol and estrone found in high concentrations in urine, especially during pregnancy. test (SalEst(R) System). A-Fem is a medical technology company with multiple platforms targeting unmet needs in women's health. The Company has developed three proprietary platforms: the inSync(R) miniform, the PadKit(R) Sample Collection System and Rapid-Sense(R) Diagnostics. A-Fem currently markets the inSync miniform, an alternative to tampons, pads and liners for light flow protection. The PadKit, currently in pre-clinical trials, utilizes the miniform as an alternative collection method for Pap test Pap test, Pap smear, or Papanicolaou test (păp'ənē`kəlou), medical procedure used to detect cancer of the uterine cervix. sample collection. Rapid-Sense is a unique point-of-care diagnostic that provides quantifiable results. For more information, visit A-Fem's website at www.afem.com. The discussion in this press release regarding A-Fem Medical Corporation ("Company") contains forward looking statements (as defined in Section 27A of the Securities Act of 1933, as amended) that involve risks and uncertainties. Actual results could differ materially from those projected in the forward looking statements as a result of a number of factors. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion